Estrada-Bernal A, Le AT, Doak AE, Tirunagaru VG, et al. Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes. Clin Cancer Res 2021;27:1463-1475.
PMID: 33355298